slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 22,651-22,680
Pages 2,605
Rows per page 30
Component
22,651-22,680 of 78,129
18
The slide uses a dot plot to show search space diversity and a bar chart to compare binding rates against various baselines.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence2 hits
19
The slide demonstrates that Variant A* shows higher potency than the wild-type trastuzumab in both binding and ADCC assays.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence2 hits
25
The slide uses a process flow (1: Data generation, 2: Model training) followed by validation results (scatter plot and correlation table).Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction2 hits
38
The slide uses a before-after framing to demonstrate competitive advantage in speed and cost.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 2 hits
09
The slide highlights a 77% viscosity reduction for Infliximab and a 45-78% reduction for Ipilimumab.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle2 hits
21
The slide uses stacked bar charts to detail expense categories and a table for peer benchmarking.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action2 hits
22
Includes a disclaimer about hypothetical scenarios and a project timeline matrix.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action2 hits
24
The slide compares two different drugs (baricitinib and deuruxolitinib) using their respective clinical trial data (BRAVE AA1 and THRIVE AA1).Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 2 hits
19
The chart combines a bar chart for spending ($Bn) and a line chart for the rate of change (%).FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · SolutionLoop · Why Now2 hits
12
Waterfall plot and spider plot used to visualize clinical efficacy.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · Traction2 hits
18
Includes specific patient case reports (Pt #21A-06 and Pt #21A-04) showing tumor response metrics.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 2 hits
32
The slide uses two distinct chart types to show longitudinal dynamics (line chart) and best response (waterfall chart) for the CA-125 biomarker.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 2 hits
33
The slide uses a dual-axis chart to correlate tumor size (SLD) and biomarker (CA-125) response to the Olvi-Vec intervention.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 2 hits
36
The slide uses a combination of immunological data (ELISPOT) and clinical imaging data (SLD) to show causality between immune response and tumor shrinkage.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 2 hits
37
The slide uses clinical data (cytokine levels and PD-L1 staining) to support the mechanism of action.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 2 hits
26
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction2 hits
49
Includes unpublished internal data alongside referenced Winograd et al. 2015 study.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps2 hits
19
The slide uses a bridge-like structure to connect historical performance to a future target.Sonder | Investor Presentation Deck | 27 slides · Sonder
Pitch deck Investor relations Beat · Financials2 hits
09
The chart uses a dual-representation: a line graph for total applications and a bar chart for issued patents.Sonos | Investor Presentation Deck | 21 slides · Sonos
Pitch deck Investor relations Beat · The BreakthroughLoop · Golden Circle2 hits
13
Includes GAAP and non-GAAP metrics with regional sales mix data.Sonos | Results Presentation Deck | 40 slides · Sonos
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
25
The chart uses a combination of a line graph for total applications and a bar chart for issued patents.Sonos | Results Presentation Deck | 40 slides · Sonos
Conference presentation Investor relations Beat · Future Vision2 hits
05
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · NeedLoop · Logic Chain2 hits
06
The slide shows a downward trend in both operating expenses and adjusted EBITDA losses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain2 hits
08
The slide uses a before-after structure to show the transition from historical active unwinds to a future natural run-off profile.UBS | Results Presentation Deck | 31 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Before After2 hits
27
The slide uses two waterfall charts to explain the bridge between two quarters for capital and risk metrics.UBS | Results Presentation Deck | 31 slides · UBS
Conference presentation Investor relations Beat · Action2 hits
17
The slide uses a dark theme with distinct color coding for GOV (pink/purple) and Revenue (blue).Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Beat · TractionLoop · Golden Circle2 hits
19
The slide uses a combination of bar charts for absolute values and line charts for margin percentages.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Beat · TractionLoop · Golden Circle2 hits
10
The chart shows a consistent upward trend in both GOV and Revenue over the 7-quarter period.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction2 hits
11
Includes footnotes regarding non-GAAP reconciliation and noncontrolling interests.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction2 hits
11
Slide 11 of a presentation deck.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Action2 hits